CA
BSX icon

Clearstead Advisors’s Boston Scientific BSX Stock Holding History

Clearstead Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.67M Buy
26,552
+6,066
+30% +$485K 0.02% 403
2025
Q4 		$1.95M Buy
20,486
+11,492
+128% +$1.13M 0.02% 334
2025
Q3 		$878K Sell
8,994
-2,966
-25% -$307K 0.01% 493
2025
Q2 		$1.28M Buy
11,960
+9,033
+309% +$914K 0.02% 389
2025
Q1 		$295K Buy
2,927
+620
+27% +$62.4K ﹤0.01% 717
2024
Q4 		$206K Sell
2,307
-54
-2% -$4.75K ﹤0.01% 846
2024
Q3 		$198K Buy
2,361
+67
+3% +$5.28K ﹤0.01% 865
2024
Q2 		$177K Buy
2,294
+444
+24% +$32.5K ﹤0.01% 853
2024
Q1 		$135K Sell
1,850
-16
-0.9% -$1.03K 0.01% 541
2023
Q4 		$108K Sell
1,866
-350
-16% -$18.7K 0.01% 570
2023
Q3 		$117K Buy
2,216
+1,362
+159% +$71.4K ﹤0.01% 689
2023
Q2 		$46.2K Hold
854
– – ﹤0.01% 739
2023
Q1 		$42.7K Buy
854
+195
+30% +$9.19K ﹤0.01% 698
2022
Q4 		$30.5K Buy
+659
New +$28.5K ﹤0.01% 723
2022
Q2 		– Sell
-77
Closed -$3K – 1291
2022
Q1 		$3K Buy
77
+6
+8% +$260 ﹤0.01% 1139
2021
Q4 		$3K Hold
71
– – ﹤0.01% 1054
2021
Q3 		$3K Sell
71
-125
-64% -$5.53K ﹤0.01% 1074
2021
Q2 		$8K Buy
+196
New +$8.25K ﹤0.01% 818

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Clearstead Advisors's BSX Position: Q1 2026 in Review

Clearstead Advisors increased its Boston Scientific (BSX) stake by 30% in Q1 2026, buying an estimated $485K and bringing the position to 26,552 shares worth $1.67M. The position accounts for 0.02% of the portfolio, ranked #403.

Clearstead Advisors first reported a position in BSX in Q2 2021 and has held it in 18 quarters since. The position peaked at $1.95M in Q4 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Clearstead Advisors held 26,552 shares of Boston Scientific worth $1.67M as of Q1 2026.
  • Clearstead Advisors bought 6,066 Boston Scientific shares in Q1 2026, an estimated $485K.
  • Boston Scientific made up 0.02% of Clearstead Advisors's portfolio in Q1 2026, its #403 holding.
  • Clearstead Advisors first reported a position in Boston Scientific in Q2 2021 and has held it in 18 quarters since.
  • Clearstead Advisors's Boston Scientific position peaked at $1.95M in Q4 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Clearstead Advisors's 13F filing for Q1 2026, filed 6 May 2026.